Chris Corre
@correlab.bsky.social did:plc:iem6gv5uidcefocmwp5wd232
Professor in Engineering Biology @University of Warwick
Bei Bluesky seit
- Follower
- 57
- Folgt
- 76
- Posts
- 1
- Tage in Ranglisten
- 0
Zusammenfassung
Chris Corre (@correlab.bsky.social) ist seit 11 August 2025 auf Bluesky. Das Konto hat 57 Follower, folgt 76 Konten und hat 1 Posts veröffentlicht.
Ranglisten-Platzierungen
Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.
Dieses Konto war noch in keiner Tagesrangliste.
Zuletzt gelikte Posts
Öffentliche Likes aus dem Bluesky-Netzwerk.
Pleased to share that yesterday I passed my viva. Huge thanks to my examiners @correlab.bsky.social and @profjamesmason.bsky.social for making this a great experience. Plus a massive thanks to my supervisors @friendlymicrobe.bsky.social & @sebperrier.bsky.social for their endless support & guidance.
Post anzeigenAnother new Dr in the house! Massive congratulations to @nreddy.bsky.social 🥳 Thanks to @sebperrier.bsky.social for the continuing teamwork on antimicrobial polymers & excellent PhD students, and to @correlab.bsky.social and @profjamesmason.bsky.social for examining. #MicroSky
Post anzeigenBritish and Australian chemists have discovered a powerful new antibiotic called pre-methylenomycin C lactone, hiding in a well-known soil bacterium. This molecule kills drug-resistant bacteria without triggering resistance. buff.ly/YlXaONo #ShareGoodNewsToo
Post anzeigenA thread about how microbiologists persuaded a bacterium to make an exciting new antibiotic candidate - work by @challis-group.bsky.social @correlab.bsky.social and colleagues #MicroSky
Post anzeigenHere’s @tosinorababa.bsky.social & @nreddy.bsky.social showing the ways we grow bacteria in the lab to simulate conditions in an infected patient - we have models of #CysticFibrosis lung, endotracheal tube & chronic wound, all compliant with efforts to reduce & replace animals in research.
Post anzeigen
Blockierte Konten
Blockierungen sind auf Bluesky öffentlich.
Dieses Konto blockiert niemanden.